# A critical guideline for controlling monocyte-derived macrophages phenotypes

**Authors:** Giorgia Moschetti, Doriana Oliveri, Valeria De Matteis, Marta Zaccaria, Diego Rondelli, Anna Griego, Edoardo Scarpa, Loris Rizzello

PMC · DOI: 10.3389/fimmu.2025.1694625 · Frontiers in Immunology · 2026-02-23

## TL;DR

This paper reviews how to better model macrophage behavior in the lab using monocyte-derived macrophages, focusing on improving consistency and relevance.

## Contribution

The paper provides a critical review and methodological strategies to enhance the use of monocyte-derived macrophages in macrophage research.

## Key findings

- Monocyte-derived macrophages differ from tissue-resident macrophages in origin and function.
- Current methods for modeling macrophages face challenges in reproducibility and physiological relevance.
- The paper proposes strategies to improve macrophage research using controlled in vitro models.

## Abstract

Macrophages (Mϕ) are an extremely heterogeneous and rapidly adapting set of innate immune cells that are scattered throughout all tissues in humans from mid-gestation onwards. Their original definition as key players in phagocytosis and defense against pathogens is too restrictive nowadays, as Mϕ are central to tissue homeostasis, repair, and complex immune regulations involving adaptive immunity. The Mϕ exhibit different ontogenies, originating from either embryonic progenitors or bone marrow, and their fate is shaped by tissue-specific microenvironments, which determine their adaptive phenotypes. This results in functional flexibility, exemplified by their ability to polarize into pro- (M1) or anti- (M2) inflammatory states in response to environmental cues. Such a dynamic process is critical for resolving infections, repairing tissue, and maintaining immune balance. Dysregulated Mϕ polarization is indeed implicated in various pathologies, including chronic inflammation, cancer, and fibrosis. Despite their importance, the study of tissue-resident Mϕ is still limited by technical challenges related to their isolation, maintenance, and donor variability. As an alternative, monocyte-derived macrophages (MDMs) represent an easier in vitro system to model human Mϕ biology under controlled conditions. However, MDMs differ from tissue-resident Mϕ in their developmental origin and functional specialization. This review outlines the key principles and limitations of MDM-based models, discusses commonly used differentiation protocols, and proposes methodological strategies to enhance reproducibility and physiological relevance in macrophage research.

## Linked entities

- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** CD68 (CD68 molecule) [NCBI Gene 968] {aka GP110, LAMP4, SCARD1}, CD80 (CD80 molecule) [NCBI Gene 941] {aka B7, B7-1, B7.1, BB1, CD28LG, CD28LG1}, TNFRSF9 (TNF receptor superfamily member 9) [NCBI Gene 3604] {aka 4-1BB, CD137, CDw137, ILA, IMD109}, CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, CD200 (CD200 molecule) [NCBI Gene 4345] {aka MOX1, MOX2, MRC, OX-2}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, ANXA5 (annexin A5) [NCBI Gene 308] {aka ANX5, CPB-I, ENX2, HEL-S-7, PP4, RPRGL3}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, CCL24 (C-C motif chemokine ligand 24) [NCBI Gene 6369] {aka Ckb-6, MPIF-2, MPIF2, SCYA24}, IL12B (interleukin 12B) [NCBI Gene 3593] {aka CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}, HP (haptoglobin) [NCBI Gene 3240] {aka HP2ALPHA2, HPA1S}, TRBV20OR9-2 (T cell receptor beta variable 20/OR9-2 (non-functional)) [NCBI Gene 6962] {aka CDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O}, CCL5 (C-C motif chemokine ligand 5) [NCBI Gene 6352] {aka D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228}, CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348] {aka G0S19-1, LD78, LD78ALPHA, MIP-1-alpha, MIP1A, SCI}, IL2RA (interleukin 2 receptor subunit alpha) [NCBI Gene 3559] {aka CD25, IDDM10, IL2R, IMD41, TCGFR, p55}, CD200R1 (CD200 receptor 1) [NCBI Gene 131450] {aka CD200R, HCRTR2, MOX2R, OX2R}, CXCL9 (C-X-C motif chemokine ligand 9) [NCBI Gene 4283] {aka CMK, Humig, MIG, SCYB9, crg-10}, MFSD11 (major facilitator superfamily domain containing 11) [NCBI Gene 79157] {aka ET}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, FCGR1A (Fc gamma receptor Ia) [NCBI Gene 2209] {aka CD64, CD64A, FCG1, FCGR1, FCRI, FcgammaRI}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CD209 (CD209 molecule) [NCBI Gene 30835] {aka CDSIGN, CLEC4L, DC-SIGN, DC-SIGN1, hDC-SIGN}, TLR2 (toll like receptor 2) [NCBI Gene 7097] {aka CD282, TIL4}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, CCL22 (C-C motif chemokine ligand 22) [NCBI Gene 6367] {aka A-152E5.1, ABCD-1, DC/B-CK, MDC, SCYA22, STCP-1}, CD163 (CD163 molecule) [NCBI Gene 9332] {aka M130, MM130, SCARI1}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, ABCA1 (ATP binding cassette subfamily A member 1) [NCBI Gene 19] {aka ABC-1, ABC1, CERP, HDLCQTL13, HDLDT1, HPALP1}, CSF2RA (colony stimulating factor 2 receptor subunit alpha) [NCBI Gene 1438] {aka CD116, CDw116, CSF2R, CSF2RAX, CSF2RAY, CSF2RX}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, MARCO (macrophage receptor with collagenous structure) [NCBI Gene 8685] {aka SCARA2, SR-A6}, CCL17 (C-C motif chemokine ligand 17) [NCBI Gene 6361] {aka A-152E5.3, ABCD-2, SCYA17, TARC}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, IL13 (interleukin 13) [NCBI Gene 3596] {aka IL-13, P600}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, CSF1R (colony stimulating factor 1 receptor) [NCBI Gene 1436] {aka BANDDOS, C-FMS, CD115, CSF-1R, CSFR, FIM2}, JUNB (JunB proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3726] {aka AP-1}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, CSF2 (colony stimulating factor 2) [NCBI Gene 281095] {aka CSF, GM-CSF, GMCSF}, TREM2 (triggering receptor expressed on myeloid cells 2) [NCBI Gene 54209] {aka AD17, PLOSL2, TREM-2, Trem2a, Trem2b, Trem2c}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, CD40LG (CD40 ligand) [NCBI Gene 959] {aka CD154, CD40L, HIGM1, IGM, IMD3, T-BAM}, IL10 (interleukin 10) [NCBI Gene 281246] {aka IF2A}, CCL4 (C-C motif chemokine ligand 4) [NCBI Gene 6351] {aka ACT2, AT744.1, G-26, HC21, LAG-1, LAG1}, LIPA (lipase A, lysosomal acid type) [NCBI Gene 3988] {aka CESD, LAL}, CCL18 (C-C motif chemokine ligand 18) [NCBI Gene 6362] {aka AMAC-1, AMAC1, CKb7, DC-CK1, DCCK1, MIP-4}, IL23A (interleukin 23 subunit alpha) [NCBI Gene 51561] {aka IL-23, IL-23A, IL23P19, P19, SGRF}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CD86 (CD86 molecule) [NCBI Gene 942] {aka B7-2, B7.2, B70, BU63, CD28LG2, CD86 v6}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, FCGR3A (Fc gamma receptor IIIa) [NCBI Gene 2214] {aka CD16-II, CD16A, FCG3, FCGR3, FCRIIIA, FcGRIIIA}, CD69 (CD69 molecule) [NCBI Gene 969] {aka AIM, BL-AC/P26, CLEC2C, EA1, GP32/28, MLR-3}, CSF1 (colony stimulating factor 1) [NCBI Gene 1435] {aka CSF-1, MCSF, PG-M-CSF}, CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}, IL34 (interleukin 34) [NCBI Gene 146433] {aka C16orf77, IL-34}, MRC1 (mannose receptor C-type 1) [NCBI Gene 4360] {aka CD206, CLEC13D, CLEC13DL, MMR, MRC1L1, bA541I19.1}
- **Diseases:** Gaucher disease (MESH:D005776), pulmonary inflammation (MESH:D011014), pulmonary alveolar proteinosis (MESH:D011649), steatohepatitis (MESH:D005234), inflammatory monocyte and NK cell (MESH:D000077428), metabolic disorders (MESH:D008659), intrahepatic cholestasis (MESH:D002780), inflammation (MESH:D007249), neurodegeneration (MESH:D019636), injury (MESH:D014947), respiratory infections (MESH:D012141), fibrosis (MESH:D005355), liver fibrosis (MESH:D008103), cancer (MESH:D009369), alcoholic liver disease (MESH:D008108), infectious diseases (MESH:D003141), sepsis (MESH:D018805), septic shock (MESH:D012772), necrosis (MESH:D009336), MDM (MESH:D007645), atherosclerosis (MESH:D050197), mycoplasma (MESH:D009175), metastasis (MESH:D009362), cytotoxic (MESH:D064420), MDMs (MESH:D055501), infection (MESH:D007239), myocardial infarction (MESH:D009203), COVID-19 (MESH:D000086382), immune dysfunctions (MESH:D007154)
- **Chemicals:** iron (MESH:D007501), nitric oxide (MESH:D009569), FCCP (MESH:D002259), Zymosan (MESH:D015054), hydroxyl radical (MESH:D017665), 2',7'-dichlorodihydrofluorescein (MESH:C065013), L-citrulline (MESH:D002956), acid (MESH:D000143), desmosterol (MESH:D003897), oxygen (MESH:D010100), succinate (MESH:D019802), brefeldin A (MESH:D020126), singlet oxygen (MESH:D026082), Trypan blue (MESH:D014343), 2-DG (MESH:D003847), 7-AAD (MESH:C025942), TCA (MESH:D014233), carbon monoxide (MESH:D002248), lactate (MESH:D019344), TBHP (MESH:D020122), EDTA (MESH:D004492), prostaglandins (MESH:D011453), lipid (MESH:D008055), LPS (MESH:D008070), antimycin A (MESH:D000968), ATP (MESH:D000255), glutamine (MESH:D005973), rotenone (MESH:D012402), citrate (MESH:D019343), glucose (MESH:D005947), ROS (MESH:D017382), calcium (MESH:D002118), oligomycin (MESH:D009840), NAD+ (MESH:D009243), PBS (MESH:D007854), monensin (MESH:D008985), H2O2 (MESH:D006861), CFSE (-), superoxide (MESH:D013481), DCA (MESH:D003999), hydrogen sulphide (MESH:D006862), NO (MESH:D009614), dextran (MESH:D003911), fatty acid (MESH:D005227), L-arginine (MESH:D001120), carbohydrate (MESH:D002241), heme (MESH:D006418), nitrite (MESH:D009573), MTT (MESH:C070243), RNS (MESH:D026361)
- **Species:** Mphi [taxon 1847729], Mycoplasma (genus) [taxon 2093], Escherichia coli (E. coli, species) [taxon 562], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Mus musculus (house mouse, species) [taxon 10090], Bos taurus (bovine, species) [taxon 9913], Danio rerio (leopard danio, species) [taxon 7955], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Cell lines:** U-937 — Homo sapiens (Human), Adult acute monocytic leukemia, Cancer cell line (CVCL_0007), M1 — Homo sapiens (Human), Melanoma, Cancer cell line (CVCL_W290), THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12968255/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12968255/full.md

## References

165 references — full list in the complete paper: https://tomesphere.com/paper/PMC12968255/full.md

---
Source: https://tomesphere.com/paper/PMC12968255